Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia.
McMahon KM, Scielzo C, Angeloni NL, Deiss-Yehiely E, Scarfo L, Ranghetti P, Ma S, Kaplan J, Barbaglio F, Gordon LI, Giles FJ, Thaxton CS, Ghia P.
McMahon KM, et al. Among authors: giles fj.
Oncotarget. 2017 Feb 14;8(7):11219-11227. doi: 10.18632/oncotarget.14494.
Oncotarget. 2017.
PMID: 28061439
Free PMC article.